Cart
sales@molnova.com
BMS 182874 hydrochloride
CAS No. 1215703-04-0
BMS 182874 hydrochloride( —— )
Catalog No. M23383 CAS No. 1215703-04-0
BMS 182874 hydrochloride is a nonpeptide endothelin (El) receptor antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 149 | In Stock |
|
| 2MG | 93 | In Stock |
|
| 5MG | 143 | In Stock |
|
| 10MG | 216 | In Stock |
|
| 25MG | 362 | In Stock |
|
| 50MG | 494 | In Stock |
|
| 100MG | 686 | In Stock |
|
| 200MG | 926 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBMS 182874 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionBMS 182874 hydrochloride is a nonpeptide endothelin (El) receptor antagonist.
-
DescriptionBMS 182874 hydrochloride is a nonpeptide endothelin (El) receptor antagonist.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetEndothelin Receptor
-
RecptorET-A
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1215703-04-0
-
Formula Weight381.88
-
Molecular FormulaC17H20ClN3O3S
-
Purity>98% (HPLC)
-
SolubilityDMSO:100mM
-
SMILESCC1=C(NS(=O)(C2=CC=CC3=C2C=CC=C3N(C)C)=O)ON=C1C.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.MARIA L WEBB, J. EILEEN BIRD, EDDIE C. K. LIU, PATRICIA M. ROSE, RANDY SERAFINO, PHILIP D. STEIN and SUZANNE MORELAND. BMS-182874 is a selective, nonpeptide endothelin ETA receptor antagonist. JPET 272:1124-1134, 1995.
molnova catalog
related products
-
Ro 46-2005
Ro 46-2005 is the first synthetic orally active nonpeptide antagonist of endothelin receptor with equipotent potency (IC50=0.2-0.5 uM) for ETA and ETB.
-
Nebentan potassium
Nebentan potassium (YM598) is an orally active and selective nonpeptide endothelin receptor (ETA receptor) antagonist.
-
BQ-788
BQ-788 is a selective and potent ETB receptor antagonist with potential hypertensive activity.BQ-788 inhibits ET-1 binding to ETB receptors and inhibits exogenous ET-1-induced elevation of coronary artery perfusion pressure.
